Search filters

List of works by Maissa El-Raziky

Accurate Prediction of Response to Interferon-based Therapy in Egyptian Patients with Chronic Hepatitis C Using Machine-learning Approaches

scholarly article published August 2012

Changes in liver stiffness measurements and fibrosis scores following sofosbuvir based treatment regimens without interferon.

scientific article published on 8 February 2017

Circulating Hypermethylated RASSF1A as a Molecular Biomarker for Diagnosis of Hepatocellular Carcinoma

scientific article published on 25 June 2017

Coinfection with hepatitis C virus and schistosomiasis: fibrosis and treatment response.

scientific article published on May 2013

Effect of Direct-Acting Agents on Fibrosis Regression in Chronic Hepatitis C Virus Patients' Treatment Compared with Interferon-Containing Regimens.

scientific article

Effectiveness of ravidasvir plus sofosbuvir in interferon-naïve and treated patients with chronic hepatitis C genotype-4.

scientific article published on 18 September 2017

Evaluation of serum biomarkers of fibrosis and injury in Egyptian patients with chronic hepatitis C.

scientific article published on 24 January 2007

Hepatic fibrosis and serum alpha-fetoprotein (AFP) as predictors of response to HCV treatment and factors associated with serum AFP normalisation after treatment

scientific article published on September 2013

High Dose of Silymarin in Patients with Decompensated Liver Disease: A Randomized Controlled Trial

scientific article published in November 2017

High SVR rate following retreatment of non-sustained virological responders to sofosbuvir based anti-HCV therapies regardless of RAS testing: A real-life multicenter study

scientific article published on 23 June 2019

How to optimize HCV therapy in genotype 4 patients.

scientific article published on February 2013

Human leukocyte antigen class II alleles (DQB1 and DRB1) as predictors for response to interferon therapy in HCV genotype 4

scientific article published on 14 March 2013

IP-10 Serum Level in Chronic Hepatitis C Virus Patients: Relation to Fibrosis and Response to Combined Interferon/Ribavirin Therapy.

scientific article published on 14 May 2015

ITPA gene polymorphism (94C>A) effects on ribavirin-induced anemia during therapy in Egyptian patients with chronic hepatitis C.

scientific article

Impact of old Schistosomiasis infection on the use of transient elastography (Fibroscan) for staging of fibrosis in chronic HCV patients.

scientific article

Impact of vitamin D supplementation on sustained virological response in chronic hepatitis C genotype 4 patients treated by pegylated interferon/ribavirin.

scientific article published on 25 July 2014

Improvement of steatosis after interferon therapy in HCV genotype 4 is related to weight loss.

scientific article published on March 2009

Is rs8099917 polymorphism of IL-28B gene a good predictor of response to therapy of HCV than rs12979860? An Egyptian study.

scientific article

Liver fibrosis staging through a stepwise analysis of non-invasive markers (FibroSteps) in patients with chronic hepatitis C infection

scientific article published on 20 March 2013

NS5A sequence heterogeneity of hepatitis C virus genotype 4a predicts clinical outcome of pegylated-interferon-ribavirin therapy in Egyptian patients

scientific article

Non-invasive prediction of hepatic fibrosis in patients with chronic HCV based on the routine pre-treatment workup.

scientific article published on November 2012

Optimizing treatment for HCV genotype 4: PEG-IFN alfa 2a vs. PEG-IFN alfa 2b; the debate continues.

scientific article published on February 2014

Planning and prioritizing direct acting antivirals treatment for HCV patients in countries with limited resources: lessons from the Egyptian experience.

scientific article published on 6 December 2017

Predictors of Virological Response in 3,235 Chronic HCV Egyptian Patients Treated with Peginterferon Alpha-2a Compared with Peginterferon Alpha-2b Using Statistical Methods and Data Mining Techniques

scientific article

Real life Egyptian experience of efficacy and safety of Simeprevir/Sofosbuvir therapy in 6211 chronic HCV genotype IV infected patients

scientific article

Regulatory and activated effector T cells in chronic hepatitis C virus: Relation to autoimmunity.

scientific article published on October 2016

Response to Real life Egyptian experience of efficacy / safety of Simeprevir\ Sofosbuvir in HCV genotype IV.

scientific article

Simeprevir plus sofosbuvir for eight or 12 weeks in treatment-naïve and treatment-experienced hepatitis C virus genotype 4 patients with or without cirrhosis.

scientific article

Single nucleotide polymorphism at exon 7 splice acceptor site of OAS1 gene determines response of hepatitis C virus patients to interferon therapy.

scientific article

Sofosbuvir-based treatment regimens: real life results of 14 409 chronic HCV genotype 4 patients in Egypt.

scientific article

The adverse effects of interferon-free regimens in 149 816 chronic hepatitis C treated Egyptian patients.

scientific article

The future for the treatment of genotype 4 chronic hepatitis C.

scientific article published on February 2012

Value of α-smooth muscle actin and glial fibrillary acidic protein in predicting early hepatic fibrosis in chronic hepatitis C virus infection.

scientific article published on June 2010

Paulina is supported by:

About Paulina

Help